The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

World’s First “Universal” Robotics Software Platform BOW Raises £4 Million Seed to Reduce Cost and Complexity of Programming ...

LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...

Listen to this article Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership with state ...

Ltd., known as INSEE Cement, Sri Lanka’s leading and only fully integrated cement manufacturer, has announced the appointment ...

U.K. stocks are slightly down Monday morning, due largely to weakness in the mining sector after data showed a contraction in the ...